Jay S. Duker Eye Point Pharmaceuticals, Inc. (EYPT) insider trading activity

EYPT Quotes by TradingView

Jay S. Duker is President and CEO of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 77,752 shares of EYPT, which is worth approximately $921,361. The most recent transaction as insider was on Feb 09, 2023, when has been sold 11,967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.8K
680.25% 3M change
6.94% 12M change
Total Value Held $921,361

Jay S. Duker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
11,967 Added 26.4%
33,369 Common Stock
Nov 01 2022
SELL
Payment of exercise price or tax liability
$24,276 $5.42 p/Share
4,479 Reduced 17.31%
21,402 Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
-
15,258 Added 37.09%
25,881 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
4,966 Added 31.86%
10,623 Common Stock

Also insider at

SESN
Sesen Bio, Inc. Healthcare
Director
JSD

Jay S. Duker

President and CEO
Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EYPT